Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are

Updated on: December 18,2023 12

Stop marginalising men with breast cancer

by Kerry Quincey,The ConversationCredit: AI-generated imageBreast cancer is the most common cancer in theUKand the leading cancerin women worldwide. Approximately 150 cases are

Updated on:December 18,2023 12

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on: December 19,2023 10

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on:December 19,2023 10

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p

Updated on: December 25,2023 5

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p

Updated on:December 25,2023 5

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on: December 22,2023 12

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on:December 22,2023 12

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023 6

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023 6

Researchers identify safety of a potential new treatment to manage complications from sickle cell disease

byUniversity of Maryland School of MedicineCredit: National Institutes of HealthA drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ d

Updated on: April 30,2024 0

Researchers identify safety of a potential new treatment to manage complications from sickle cell disease

byUniversity of Maryland School of MedicineCredit: National Institutes of HealthA drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ d

Updated on:April 30,2024 0

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on: January 26,2024 23

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on:January 26,2024 23

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce

Updated on: December 27,2023 10

Scientists develop powerful AI algorithm to gain new insights into deadly glioblastoma

by Sylvester Comprehensive Cancer CenterThe SPHINKS network for the precision targeting of master kinases in glioblastoma. Credit: Antonio Iavarone, M.D.Scientists at Sylvester Comprehensive Cancer Ce

Updated on:December 27,2023 10

A promising treatment for ovarian cancer

by Erin Matthews,Canadian Light SourceOvary. Credit: Public DomainOver 20,000 women across the U.S. and Canada are diagnosed with ovarian cancer annually. The symptoms of this disease are often

Updated on: March 12,2024 10

A promising treatment for ovarian cancer

by Erin Matthews,Canadian Light SourceOvary. Credit: Public DomainOver 20,000 women across the U.S. and Canada are diagnosed with ovarian cancer annually. The symptoms of this disease are often

Updated on:March 12,2024 10

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Updated on: December 22,2023 10

Combination of chemo and diabetes drugs shows potential for treating Ewing sarcoma

byHouston MethodistStephen T. Wong, Ph.D., Associate Director, Cores, Biostatistics and BioinformaticsHouston Methodist Cancer Center. Credit: Houston MethodistEwing sarcoma, an aggressive tumor

Updated on:December 22,2023 10

Viewpoint: FDA needs to ensure that information on dense breast notifications are clear and understandable to all

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainYou are among the women who dutifully gets an annual mammogram. Year after year, the results are "normal." But af

Updated on: December 23,2023 10

Viewpoint: FDA needs to ensure that information on dense breast notifications are clear and understandable to all

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainYou are among the women who dutifully gets an annual mammogram. Year after year, the results are "normal." But af

Updated on:December 23,2023 10

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on: March 20,2024 11

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on:March 20,2024 11